Drug
Stiripentol
Stiripentol: highest development phase Phase 3, developed by Biocodex. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocodex
Trials
| Drug | Phase | Indication |
|---|---|---|
| Stiripentol Oral Capsule NCT06465472 | Phase 3 | Primary Hyperoxaluria Type 1 |
Latest
No recent events.
Follow Stiripentol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.